FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Qualgen LLC | 034474862 | 69761-061 | 69761-061-01 | Estradiol | 6 mg | 2024-2 | valid | 2026-11-08 | |
| Qualgen LLC | 034474862 | 69761-212 | 69761-212-01 | Anastrozole; Testosterone | 20 mg; 200 mg | 2024-2 | valid | 2026-11-08 | |
| Qualgen LLC | 69761-061 | 69761-061-01 | Estradiol | Estradiol | 6 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-251 | 69761-251-01 | Estradiol / Stearic Acid | Estradiol | 25 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-101 | 69761-101-01 | Estradiol / Stearic Acid | Estradiol | 10 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-201 | 69761-201-01 | Estradiol / Stearic Acid | Estradiol | 20 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-151 | 69761-151-01 | Estradiol / Stearic Acid | Estradiol | 15 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-181 | 69761-181-01 | Estradiol / Stearic Acid | Estradiol | 18 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-121 | 69761-121-01 | Estradiol / Stearic Acid | Estradiol | 12.5 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-873 | 69761-873-01 | Testosterone | Testosterone | 87.5 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-203 | 69761-203-01 | Testosterone | Testosterone | 200 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-503 | 69761-503-01 | Testosterone | Testosterone | 50 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-103 | 69761-103-01 | Testosterone | Testosterone | 100 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-212 | 69761-212-01 | Testosterone / Anastrozole | Testosterone, Anastrozole | 20 mg; 200 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-372 | 69761-372-01 | Testosterone / Stearic Acid | Testosterone | 37.5 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-122 | 69761-122-01 | Testosterone / Stearic Acid | Testosterone | 12.5 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-872 | 69761-872-01 | Testosterone / Stearic Acid | Testosterone | 87.5 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-102 | 69761-102-01 | Testosterone / Stearic Acid | Testosterone | 100 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-252 | 69761-252-01 | Testosterone / Stearic Acid | Testosterone | 25 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-502 | 69761-502-01 | Testosterone / Stearic Acid | Testosterone | 50 mg | 2024-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-202 | 69761-202-01 | Testosterone / Stearic Acid | Testosterone | 200 mg | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-435 | 70092-435-46 | Acetaminophen 10 mg/ml 10 ml syr PF | Acetaminophen 10 mg/ml 10 ml syr PF | 100 mg/10 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-004 | 70092-004-37 | Amiodarone 450mg add to 250ml D5W IVB | Amiodarone 450mg add to 250ml D5W IVB | 450 mg/250 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-229 | 70092-229-43 | Atropine 0.4 mg/ml 2.5 ml- 3 ml syr | Atropine 0.4 mg/ml 2.5 ml- 3 ml syr | 1 mg/2.5 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-603 | 70092-603-46 | Cefazolin PF 100 mg/ml in 10ml SWFI syr | Cefazolin PF 100 mg/ml in 10ml SWFI syr | 1 g/10 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-604 | 70092-604-47 | Cefazolin PF 100 mg/ml in 20ml SWFI syr | Cefazolin PF 100 mg/ml in 20ml SWFI syr | 2 g/20 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-622 | 70092-622-03 | Cefazolin PF 2 g add to 100ml NS Bag | Cefazolin PF 2 g add to 100ml NS Bag | 2 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-623 | 70092-623-03 | Cefazolin PF 3 g add to 100ml NS Bag | Cefazolin PF 3 g add to 100ml NS Bag | 3 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-475 | 70092-475-50 | Dextrose PF 500mg/ml 50ml SWFI syr | Dextrose PF 500mg/ml 50ml SWFI syr | 25 g/50 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-575 | 70092-575-36 | Diltiazem PF 125mg in 125ml D5W IVB | Diltiazem PF 125mg in 125ml D5W IVB | 125 mg/125 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-477 | 70092-477-44 | Ephedrine PF 10 mg/ml in 5 ml NS syr | Ephedrine PF 10 mg/ml in 5 ml NS syr | 50 mg/5 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-455 | 70092-455-46 | Ephedrine PF 5 mg/ml in 10 ml NS syr | Ephedrine PF 5 mg/ml in 10 ml NS syr | 50 mg/10 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-478 | 70092-478-44 | Ephedrine PF 5 mg/ml in 5 ml NS syr | Ephedrine PF 5 mg/ml in 5 ml NS syr | 25 mg/5 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-617 | 70092-617-46 | Epinephrine 10 mcg/ml in 10 ml D5W syr | Epinephrine 10 mcg/ml in 10 ml D5W syr | 100 ug/10 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-103 | 70092-103-36 | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | 200 ug/100 mL; 100 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-160 | 70092-160-37 | Fent 2 mcg/ml-Bup 0.1% PF 250 ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 250 ml NS IVB | 500 ug/250 mL; 250 mg/250 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-104 | 70092-104-36 | Fent 2 mcg/ml-Bup 0.125% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.125% PF 100ml NS IVB | 200 ug/100 mL; 125 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-105 | 70092-105-37 | Fent 2 mcg/ml-Bup 0.125% PF 250ml NS IVB | Fent 2 mcg/ml-Bup 0.125% PF 250ml NS IVB | 500 ug/250 mL; 312.5 mg/250 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-108 | 70092-108-36 | Fent 2 mcg/ml-Ropiv 0.2% PF 100ml NS IVB | Fent 2 mcg/ml-Ropiv 0.2% PF 100ml NS IVB | 200 ug/100 mL; 200 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-269 | 70092-269-37 | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | Fent 2 mcg/mlBup 0.0625% PF 250ml NS IVB | 156.25 mg/250 mL; 500 ug/250 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-255 | 70092-255-75 | Fent 2mcg/mL-Bup 0.1%PF100mlNS CADDYFSFF | Fent 2mcg/mL-Bup 0.1%PF100mlNS CADDYFSFF | 200 ug/100 mL; 100 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-202 | 70092-202-75 | Fent 2mcg/mL-Bup 0.125%PF100mlNS CADDYFS | Fent 2mcg/mL-Bup 0.125%PF100mlNS CADDYFS | 200 ug/100 mL; 125 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-259 | 70092-259-75 | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADD-Y | Fent 2mcg/mL-Rop 0.2% PF 100ml NS CADD-Y | 200 mg/100 mL; 200 ug/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-250 | 70092-250-75 | Fent PF10 mcg/ml 100 ml NS CADD- C FSFF | Fent PF10 mcg/ml 100 ml NS CADD- C FSFF | 1 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-441 | 70092-441-76 | Fent2mcg/mL-Rop0.1% PF200mlNS CADD-YFSFF | Fent2mcg/mL-Rop0.1% PF200mlNS CADD-YFSFF | 400 ug/200 mL; 200 mg/200 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-440 | 70092-440-76 | Fent2mcg/mL-Rop0.2% PF200mlNS CADD-YFSFF | Fent2mcg/mL-Rop0.2% PF200mlNS CADD-YFSFF | 400 mg/200 mL; 400 ug/200 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-207 | 70092-207-37 | Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB | Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB | 400 ug/200 mL; 200 mg/200 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-092 | 70092-092-36 | Fentanyl PF 10 mcg/ml in 100 ml NS IVB | Fentanyl PF 10 mcg/ml in 100 ml NS IVB | 1 mg/100 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-093 | 70092-093-37 | Fentanyl PF 10 mcg/ml in 250 ml NS IVB | Fentanyl PF 10 mcg/ml in 250 ml NS IVB | 2500 ug/250 mL | 2024-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-444 | 70092-444-05 | Fentanyl PF 5 mcg/ml in 250 ml NS bag | Fentanyl PF 5 mcg/ml in 250 ml NS bag | 1250 ug/250 mL | 2024-2 | valid | 2026-09-18 |